PIPELINE OVERVIEW TTX is advancing multiple generations of brain-penetrant therapeutics, including our lead compounds TTX-01 and TTX-02, plus sixteen proprietary analogs in discovery. LEARN MORE ABOUT OUR LEAD PROGRAM
